Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Aug 13, 2015 · 10-Q · 44 days after period end · 0001564590-15-007261
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Net Income | -$6.01M | -$7.02M | -$8.42M | -$4.22M |
| EPS Diluted | $0.26 | -$0.47 | -$0.57 | -$0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 13, 2015 · 44 d after period end
